Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309495841> ?p ?o ?g. }
- W4309495841 abstract "Abstract Background Neurodegeneration with brain iron accumulation (NBIA) disorders are a group of neurodegenerative diseases that have in common the accumulation of iron in the basal nuclei of the brain which are essential components of the extrapyramidal system. Frequent symptoms are progressive spasticity, dystonia, muscle rigidity, neuropsychiatric symptoms, and retinal degeneration or optic nerve atrophy. One of the most prevalent subtypes of NBIA is Pantothenate kinase-associated neurodegeneration (PKAN). It is caused by mutations in the gene of pantothenate kinase 2 (PANK2) which encodes the enzyme responsible for the first reaction on the coenzyme A (CoA) biosynthesis pathway. Thus, deficient PANK2 activity induces CoA deficiency as well as low expression levels of 4′-phosphopantetheinyl proteins which are essential for mitochondrial metabolism. Methods This study is aimed at evaluating the role of alpha-lipoic acid (α-LA) in reversing the pathological alterations in fibroblasts and induced neurons derived from PKAN patients. Iron accumulation, lipid peroxidation, transcript and protein expression levels of PANK2, mitochondrial ACP (mtACP), 4′-phosphopantetheinyl and lipoylated proteins, as well as pyruvate dehydrogenase (PDH) and Complex I activity were examined. Results Treatment with α-LA was able to correct all pathological alterations in responsive mutant fibroblasts with residual PANK2 enzyme expression. However, α-LA had no effect on mutant fibroblasts with truncated/incomplete protein expression. The positive effect of α-LA in particular mutations was also confirmed in induced neurons derived from mutant fibroblasts . Conclusions Our results suggest that α-LA treatment can increase the expression levels of PANK2 and reverse the mutant phenotype in PANK2 responsive mutations. The existence of residual enzyme expression in some affected individuals raises the possibility of treatment using high dose of α-LA." @default.
- W4309495841 created "2022-11-28" @default.
- W4309495841 creator A5007579400 @default.
- W4309495841 creator A5011675522 @default.
- W4309495841 creator A5016220313 @default.
- W4309495841 creator A5031114658 @default.
- W4309495841 creator A5033110345 @default.
- W4309495841 creator A5037305277 @default.
- W4309495841 creator A5047037542 @default.
- W4309495841 creator A5047814627 @default.
- W4309495841 creator A5073630366 @default.
- W4309495841 creator A5076525128 @default.
- W4309495841 creator A5080259340 @default.
- W4309495841 creator A5085107331 @default.
- W4309495841 creator A5086348023 @default.
- W4309495841 date "2022-11-21" @default.
- W4309495841 modified "2023-10-15" @default.
- W4309495841 title "Alpha-Lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels" @default.
- W4309495841 cites W1240035049 @default.
- W4309495841 cites W134833067 @default.
- W4309495841 cites W1518778430 @default.
- W4309495841 cites W1659141691 @default.
- W4309495841 cites W1972862786 @default.
- W4309495841 cites W1976851890 @default.
- W4309495841 cites W1985526863 @default.
- W4309495841 cites W1995422084 @default.
- W4309495841 cites W2000349182 @default.
- W4309495841 cites W2003655244 @default.
- W4309495841 cites W2006439092 @default.
- W4309495841 cites W2006519535 @default.
- W4309495841 cites W2006759686 @default.
- W4309495841 cites W2006978669 @default.
- W4309495841 cites W2007258895 @default.
- W4309495841 cites W2012326456 @default.
- W4309495841 cites W2015566952 @default.
- W4309495841 cites W2021695917 @default.
- W4309495841 cites W2025657346 @default.
- W4309495841 cites W2027609269 @default.
- W4309495841 cites W2032008117 @default.
- W4309495841 cites W2035816996 @default.
- W4309495841 cites W2038514978 @default.
- W4309495841 cites W2042450476 @default.
- W4309495841 cites W2045410354 @default.
- W4309495841 cites W2054695895 @default.
- W4309495841 cites W2061675983 @default.
- W4309495841 cites W2065375187 @default.
- W4309495841 cites W2070123215 @default.
- W4309495841 cites W2071905812 @default.
- W4309495841 cites W2083233429 @default.
- W4309495841 cites W2092271268 @default.
- W4309495841 cites W2095753590 @default.
- W4309495841 cites W2102239505 @default.
- W4309495841 cites W2103416697 @default.
- W4309495841 cites W2114396660 @default.
- W4309495841 cites W2115972690 @default.
- W4309495841 cites W2132164244 @default.
- W4309495841 cites W2137598362 @default.
- W4309495841 cites W2144114000 @default.
- W4309495841 cites W2169482467 @default.
- W4309495841 cites W2340096126 @default.
- W4309495841 cites W2508958613 @default.
- W4309495841 cites W2515644495 @default.
- W4309495841 cites W2568450381 @default.
- W4309495841 cites W2625087901 @default.
- W4309495841 cites W2686521530 @default.
- W4309495841 cites W2731618083 @default.
- W4309495841 cites W2731925181 @default.
- W4309495841 cites W2753164859 @default.
- W4309495841 cites W2768976479 @default.
- W4309495841 cites W2772709248 @default.
- W4309495841 cites W2809058317 @default.
- W4309495841 cites W2884185358 @default.
- W4309495841 cites W2889510216 @default.
- W4309495841 cites W2904100843 @default.
- W4309495841 cites W2910723078 @default.
- W4309495841 cites W2911702395 @default.
- W4309495841 cites W2913955883 @default.
- W4309495841 cites W2916632364 @default.
- W4309495841 cites W2938337004 @default.
- W4309495841 cites W2967446255 @default.
- W4309495841 cites W2971038798 @default.
- W4309495841 cites W2982587120 @default.
- W4309495841 cites W2988821889 @default.
- W4309495841 cites W3005686642 @default.
- W4309495841 cites W3127281333 @default.
- W4309495841 cites W3187536286 @default.
- W4309495841 cites W3202117128 @default.
- W4309495841 cites W4210572015 @default.
- W4309495841 cites W4210653826 @default.
- W4309495841 cites W4214631129 @default.
- W4309495841 cites W4224231242 @default.
- W4309495841 cites W4291282887 @default.
- W4309495841 cites W568150818 @default.
- W4309495841 doi "https://doi.org/10.21203/rs.3.rs-2268421/v1" @default.
- W4309495841 hasPublicationYear "2022" @default.
- W4309495841 type Work @default.
- W4309495841 citedByCount "0" @default.
- W4309495841 crossrefType "posted-content" @default.
- W4309495841 hasAuthorship W4309495841A5007579400 @default.
- W4309495841 hasAuthorship W4309495841A5011675522 @default.